The executive management team at Plasma Surgical comprises professionals with exstensive experience in the medical device industry. The team's expertise spans the entire range of activities from research and development, manufacturing, quality and regulatory to product commercialization and sales and marketing in surgical equipment technology.
Peter Gibson began his career as a clinical biochemist and lecturer in clinical chemistry at the University of Edinburgh. He moved to industry in 1972, primarily to influence the design of analytical instrumentation for clinical chemistry. Since 1985, Peter has worked within the surgical instrument and implant field. He has worked closely with key surgeons and engineers to create innovative surgical instruments, including the Selector ultrasonic surgical aspirator and NeuroSensor Cerebral Blood Flow and Intracranial Pressure Monitoring System.
Peter has worked with Professor Nikolay Suslov on the development of the PlasmaJet system for the last eight years and now leads the team at Plasma Surgical as President and Chief Executive Officer.
Peter’s previous achievements include the start-up of four successful companies; a management buy-out; and management of companies in the UK, Italy, Finland, Germany, Sweden, France and the U.S. Peter Gibson’s expertise in the development of innovative products for global markets was acknowledged in 1997, when he was appointed as Royal Academy of Engineering Visiting Professor to the University of Dundee.
Professor Nikolay Suslov graduated from the Moscow Bauman Technical Institute as its top ranking student and went on to complete his doctorate on the use of plasma engines on spacecraft. Nikolay continued his research in thermal and molecular physics at the Moscow Institute of Human Morphology, the Academy of Science and several leading Moscow hospitals. He gained his professorship in recognition for his work on the interaction between plasma energy sources and live biological tissues.
During the 1990s, this research led to the development of the technology used in plasma surgery and to a series of patented inventions that are now used in the PlasmaJet system. He moved to Gothenburg, Sweden in 1998 and in 2000 co-founded Plasma Surgical.
Professor Nikolay Suslov has recently relocated to the United States and continues the development of plasma technology in his capacity as Chief Technical Officer and Executive Vice President.
Mike Dilworth is an experienced senior manufacturing executive with over 25 years of global operations experience in several large corporations. He joined Plasma Surgical in 2009 as Vice President of manufacturing and is responsible for all manufacturing worldwide.
An industrial engineer by training, Mike worked for a Siemens/Corning company pioneering the manufacture of fibre optic cables and equipment in the USA before joining Ciba Vision Corporation where he grew the Atlanta based Dailies contact lens manufacturing operation and went on to manage over 6500 employees in 16 facilities in the US, Europe and Asia as Vice President Global Manufacturing and Supply Chain.
Ian Mawhinney joined Plasma Surgical in June 2010 as Vice President of Sales and Marketing.
Ian has a very broad experience in the medical device business and joined the company from Cambridge Consultants Inc where he was Vice President for medical technology. Prior to that has held international sales and marketing positions in Europe and Asia and has worked with Radiometer and Graseby Medical in the UK, and Dräger Medical in Germany. He was Director of International Sales and Marketing for Smiths Medical in the UK and later Managing Director for Smiths Medical Asia Pacific. Ian also founded a healthcare product distributor in Malaysia.
Michael Emery joined the company in June 2011 in the position of Vice-President, Finance. Michael graduated B.S. cum laude in Accounting from Rutgers University in Newark, New Jersey and worked as a Senior Financial Analyst with Prudential Health Care before joining Solvay Pharmaceuticals in Atlanta. With Solvay, Michael worked as Controller of Finance and Accounting and managed the finance function though the acquisition of the company by Abbott Pharmaceuticals. Michael has very broad financial management experience, including international involvement and he is familiar with the medical, regulatory and research and development activities in health care business.
Steven Walsh is Vice-President of Research and Development and joined the company in June 2011. Steven graduated B.S. magna cum laude in Plastics Engineering from University of Lowell in Massachusetts, and holds both a Master of Science degree and a Doctor of Philosophy in Macromolecular Science from Case Western Reserve University. After working as manager for implantable device development for Biocontrol Technology Inc. in Indiana, Steven joined Cryolife where he worked for 11 years and became Senior Director, Biomaterials Technologies and Product Development. Before joining the company Steven held the position of Vice-President, Research and Development with Carticept Medical.
